Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) CFO Kenneth Allen Myszkowski Sells 27,167 Shares

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) CFO Kenneth Allen Myszkowski sold 27,167 shares of the company’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $19.83, for a total transaction of $538,721.61. Following the completion of the transaction, the chief financial officer now owns 473,433 […]

Leave a Reply

Your email address will not be published.

Previous post Bowen Acquisition Corp Adjourns Extraordinary Meeting to Discuss Extension Proposal
Next post Insider Selling: Cartesian Therapeutics, Inc. (NASDAQ:RNAC) CFO Sells 4,028 Shares of Stock